US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist
  • 2.4800
  • -0.0800-3.13%
Trading Mar 17 10:39 ET
6.29MMarket Cap-0.36P/E (TTM)

About GT Biopharma Company

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers. GT Biopharma has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in San Francisco, CA.

Company Profile

SymbolGTBP
Company NameGT Biopharma
Listing DateFeb 11, 2021
Issue Price5.00
Founded1965
CEOMr. Michael Breen
MarketNASDAQ
Employees1
Fiscal Year Ends12-31
Address315 Montgomery Street,10th Floor
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94104
Phone1-415-919-4040

Company Executives

  • Name
  • Position
  • Salary
  • Michael Breen
  • Executive Chairman of the Board and Interim Chief Executive Officer
  • --
  • Alan Louis Urban
  • Chief Financial Officer, Principal Accounting Officer and Secretary
  • --
  • Bruce J. Wendel
  • Vice Chairman of the Board
  • --
  • Charles J. Casamento
  • Independent Director
  • --
  • Dr. Rajesh C. Shrotriya,M.D.
  • Independent Director
  • --

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More